HARVARD BIOSCIENCE, INC. Accumulated Other Comprehensive Income
HARVARD BIOSCIENCE, INC. (HBIO) had Accumulated Other Comprehensive Income of -$12.38 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$12.38M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$12.31M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$11.67M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$12.44M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$12.38M 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$12.31M 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$11.67M 10-Q · filed 2026-08-11 |
| 2025-09-30 | -$12.44M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$11.70M 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$14.36M 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$15.67M 10-K · filed 2026-03-13 |
| 2024-09-30 | -$13.06M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$14.87M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$14.77M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$14.19M 10-K · filed 2025-03-14 |
| 2023-09-30 | -$15.28M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$14.05M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$14.65M 10-Q · filed 2023-04-26 |
| 2022-12-31 | -$15.05M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$16.18M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$13.24M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$10.73M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$10.03M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$15.00M 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$13.87M 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$14.39M 10-Q · filed 2021-05-07 |
| 2020-12-31 | -$13.07M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$11.97M 10-Q · filed 2020-11-06 |
| 2020-06-30 | -$13.70M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$14.41M 10-Q · filed 2020-05-08 |
| 2019-12-31 | -$12.69M 10-K/A · filed 2021-03-17 |
| 2019-09-30 | -$15.72M 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$14.18M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$13.71M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$13.53M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$11.59M 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$12.16M 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$9.45M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$10.68M 10-K · filed 2020-03-16 |
| 2017-09-30 | -$12.52M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$13.72M 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$15.71M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$16.66M 10-K · filed 2019-03-18 |
| 2016-09-30 | -$13.28M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$13.11M 10-Q · filed 2016-08-04 |
| 2015-12-31 | -$11.88M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$11.53M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$10.99M 10-Q · filed 2015-08-06 |
| 2015-03-31 | -$12.76M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$8.23M 10-K · filed 2017-03-17 |
| 2014-06-30 | -$2.56M 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$2.42M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$2.64M 10-K · filed 2016-04-29 |
| 2013-09-30 | -$4.37M 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$6.75M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$6.90M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$4.86M 10-K · filed 2015-03-12 |
| 2012-09-30 | -$4.73M 10-Q · filed 2012-11-08 |
| 2012-06-30 | -$6.18M 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$4.46M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$5.72M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$3.56M 10-Q · filed 2011-11-09 |
| 2011-06-30 | -$1.72M 10-Q · filed 2011-08-09 |
| 2010-12-31 | -$3.90M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |